RxDoctor Payments Data

David Allen

Urology · Athens, GANPI 1669471496

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,971 of the $2,620 with a category attached, or 75.2%. 23 manufacturers reported payments, led by Coloplast at 29.3% of the total. Reporting peaked in 2019 at $1,290 and has fallen 98.7% since, to $17 in 2024. That places this record below the midpoint for urology clinicians in GA, where the typical reported total is $4,062.

$2,620in general payments, 2019–2025

Across 110 payments — averaging $23.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coloplast$769
  • Astellas Pharma US Inc$304
  • Myovant Sciences Inc.$234
  • Bayer$191
  • Pfizer$183
  • Johnson & Johnson$145
  • plus $794 from 17 others

What the payments were for

  • Food & beverage$1,97175%
  • Education$64925%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,620 in reported general payments places this provider in the 40th percentile of 369 urology providers in Georgia.

See all urology providers in Georgia →

Other urology in Athens

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →